Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.

about

Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.

Item

http://www.wikidata.org/entity/Q38829835

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Intracoronary Bivalirudin Bolu ...... ence, and Future Applications.

@en

type

Item

label

Intracoronary Bivalirudin Bolu ...... ence, and Future Applications.

@en

prefLabel

Intracoronary Bivalirudin Bolu ...... ence, and Future Applications.

@en

P1476

Intracoronary Bivalirudin Bolu ...... ience, and Future Applications

@en

P2093

Allan S Jaffe

http://www.w3.org/2001/XMLSchema#string

Alon Schaffer

http://www.w3.org/2001/XMLSchema#string

Andrea Rognoni

http://www.w3.org/2001/XMLSchema#string

Angelo S Bongo

http://www.w3.org/2001/XMLSchema#string

Bernardo Cortese

http://www.w3.org/2001/XMLSchema#string

Chiara Cavallino

http://www.w3.org/2001/XMLSchema#string

Dominick J Angiolillo

http://www.w3.org/2001/XMLSchema#string

Italo Porto

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention

Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecte

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Protease-activated receptors in cardiovascular diseases

Bivalirudin during primary PCI in acute myocardial infarction

Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised contro

Intracoronary bivalirudin for no reflow reversal: a second chance to treat this disorder?

Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.

Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention.

P2888

s40256-016-0186-z

P304

391-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-016-0186-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Lupi

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051841394

http://www.w3.org/2001/XMLSchema#string

P698

27541144

http://www.w3.org/2001/XMLSchema#string